Qingdao Vland Biotech Co (SHSE:603739) Total Liabilities : ¥1,185 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Qingdao Vland Biotech Co Total Liabilities?

Qingdao Vland Biotech Co's Total Liabilities for the quarter that ended in Mar. 2024 was ¥1,185 Mil.

Qingdao Vland Biotech Co's quarterly Total Liabilities increased from Sep. 2023 (¥1,114.45 Mil) to Dec. 2023 (¥1,208.67 Mil) but then declined from Dec. 2023 (¥1,208.67 Mil) to Mar. 2024 (¥1,185.33 Mil).

Qingdao Vland Biotech Co's annual Total Liabilities increased from Dec. 2021 (¥536.18 Mil) to Dec. 2022 (¥844.93 Mil) and increased from Dec. 2022 (¥844.93 Mil) to Dec. 2023 (¥1,208.67 Mil).

Qingdao Vland Biotech Co Total Liabilities Historical Data

The historical data trend for Qingdao Vland Biotech Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qingdao Vland Biotech Co Total Liabilities Chart

Qingdao Vland Biotech Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

248.99

336.22

536.18

844.93

1,208.67

Qingdao Vland Biotech Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															884.75	1,051.75	1,114.45	1,208.67	1,185.33

Qingdao Vland Biotech Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Qingdao Vland Biotech Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1088.174	+	(62.06	+	58.438
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1,209

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	3034.058	-	1825.386
	=	1,209

Qingdao Vland Biotech Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1068.439	+	(62.06	+	54.827
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1,185

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	3026.159	-	1840.833
	=	1,185

Qingdao Vland Biotech Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Qingdao Vland Biotech Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Qingdao Vland Biotech Co (SHSE:603739) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Qingdao Vland Biotech Co Ltd (SHSE:603739) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1318, Wangsha Road, Room 108, Enterprise Service Center, Chengyang District, Shandong, Qingdao, CHN, 266061

Website

http://www.vlandgroup.com

Qingdao Vland Biotech Co Ltd is a biotechnology company. The company is engaged in research and development of four main product categories which are enzymes, probiotics, vaccines and animal health products.

Qingdao Vland Biotech Co (SHSE:603739) Headlines

No Headlines